Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AMED

Amedisys (AMED) Stock Price, News & Analysis

Amedisys logo

About Amedisys Stock (NASDAQ:AMED)

Key Stats

Today's Range
$100.93
$101.02
50-Day Range
$96.91
$101.01
52-Week Range
$92.44
$101.02
Volume
1.06 million shs
Average Volume
509,062 shs
Market Capitalization
$3.32 billion
P/E Ratio
39.30
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Amedisys, Inc. is a leading provider of home health, hospice and personal care services in the United States. Through its network of local care centers, the company delivers skilled nursing, physical and occupational therapies, medical social work, home health aides and related clinical support to patients in their homes. Its hospice division offers comprehensive end-of-life care, including pain management, counseling and bereavement support, designed to meet the physical, emotional and spiritual needs of terminally ill patients and their families.

The company operates under three primary service lines. Its home health segment focuses on post-acute care and chronic disease management, leveraging interdisciplinary teams to support recovery and independence. The hospice segment provides individualized care plans and around-the-clock clinical oversight, aiming to maintain patient comfort and dignity. Amedisys also offers personal care services, which include non-medical assistance with daily living activities such as bathing, dressing and meal preparation, to help clients remain safely in their homes.

Headquartered in Baton Rouge, Louisiana, Amedisys serves communities across more than 30 states and the District of Columbia. The company’s geographically diverse footprint allows it to tailor care solutions to urban, suburban and rural populations alike, often collaborating with hospitals, physician groups and payers to enhance care transitions and reduce avoidable hospital readmissions. Amedisys has pursued strategic growth through the development of new care centers and selective acquisitions aimed at expanding its service offerings and market reach.

Founded in 1982, Amedisys has grown from a regional home health provider into one of the nation’s largest post-acute care companies. The organization is led by President and Chief Executive Officer Paul F. Kusserow, who has overseen initiatives to integrate digital health tools, streamline clinical workflows and strengthen patient engagement. Under his leadership, the company has continued to focus on improving quality outcomes, enhancing caregiver support and driving operational efficiencies.

AI Generated. May Contain Errors.

Receive AMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amedisys and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AMED Stock News Headlines

Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
See More Headlines

AMED Stock Analysis - Frequently Asked Questions

Amedisys, Inc. (NASDAQ:AMED) issued its quarterly earnings data on Tuesday, July, 29th. The health services provider reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.15. The business's revenue for the quarter was up 5.2% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amedisys investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
7/29/2025
Today
8/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:AMED
CIK
896262
Employees
20,000
Year Founded
1982

Profitability

EPS (Trailing Twelve Months)
$2.57
Trailing P/E Ratio
39.30
Forward P/E Ratio
22.96
P/E Growth
1.34
Net Income
$43.23 million
Net Margins
3.56%
Pretax Margin
6.21%
Return on Equity
12.91%
Return on Assets
7.29%

Debt

Debt-to-Equity Ratio
0.26
Current Ratio
1.36
Quick Ratio
1.36

Sales & Book Value

Annual Sales
$2.40 billion
Price / Sales
1.38
Cash Flow
$6.24 per share
Price / Cash Flow
16.20
Book Value
$38.77 per share
Price / Book
2.61

Miscellaneous

Outstanding Shares
32,887,000
Free Float
32,196,000
Market Cap
$3.32 billion
Optionable
Optionable
Beta
0.89

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:AMED) was last updated on 8/5/2026 by MarketBeat.com Staff.
From Our Partners